1. Home
  2. BDSX vs LTRN Comparison

BDSX vs LTRN Comparison

Compare BDSX & LTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDSX
  • LTRN
  • Stock Information
  • Founded
  • BDSX 2005
  • LTRN 2013
  • Country
  • BDSX United States
  • LTRN United States
  • Employees
  • BDSX N/A
  • LTRN N/A
  • Industry
  • BDSX Precision Instruments
  • LTRN Biotechnology: Pharmaceutical Preparations
  • Sector
  • BDSX Health Care
  • LTRN Health Care
  • Exchange
  • BDSX Nasdaq
  • LTRN Nasdaq
  • Market Cap
  • BDSX 53.0M
  • LTRN 49.9M
  • IPO Year
  • BDSX 2020
  • LTRN 2020
  • Fundamental
  • Price
  • BDSX $7.19
  • LTRN $3.26
  • Analyst Decision
  • BDSX Strong Buy
  • LTRN Strong Buy
  • Analyst Count
  • BDSX 5
  • LTRN 1
  • Target Price
  • BDSX $32.50
  • LTRN $25.00
  • AVG Volume (30 Days)
  • BDSX 322.6K
  • LTRN 102.6K
  • Earning Date
  • BDSX 11-03-2025
  • LTRN 11-12-2025
  • Dividend Yield
  • BDSX N/A
  • LTRN N/A
  • EPS Growth
  • BDSX N/A
  • LTRN N/A
  • EPS
  • BDSX N/A
  • LTRN N/A
  • Revenue
  • BDSX $80,173,000.00
  • LTRN N/A
  • Revenue This Year
  • BDSX $19.04
  • LTRN N/A
  • Revenue Next Year
  • BDSX $26.39
  • LTRN N/A
  • P/E Ratio
  • BDSX N/A
  • LTRN N/A
  • Revenue Growth
  • BDSX 22.29
  • LTRN N/A
  • 52 Week Low
  • BDSX $3.44
  • LTRN $2.55
  • 52 Week High
  • BDSX $32.20
  • LTRN $6.12
  • Technical
  • Relative Strength Index (RSI)
  • BDSX 49.20
  • LTRN 31.85
  • Support Level
  • BDSX $7.42
  • LTRN $3.42
  • Resistance Level
  • BDSX $8.52
  • LTRN $3.55
  • Average True Range (ATR)
  • BDSX 0.85
  • LTRN 0.25
  • MACD
  • BDSX -0.05
  • LTRN -0.03
  • Stochastic Oscillator
  • BDSX 37.11
  • LTRN 21.50

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

About LTRN Lantern Pharma Inc.

Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.

Share on Social Networks: